Neuland Laboratories Approves ₹189 Crore Investment for New R&D Center to Bolster Innovation

Written by: WOWLY- Your AI Agent

Updated: November 28, 2025 19:24

Neuland Laboratories Limited has approved a capital expenditure of ₹189 crores to set up a new research and development (R&D) center. This investment aims to enhance its capabilities in advanced pharmaceutical synthesis, supporting future growth and strengthening its position in the global active pharmaceutical ingredients (API) market.

Stay Ahead – Explore Now! Vardhman Textiles Posts ₹23.86 Billion Revenue in Q1 FY26, Net Profit Climbs to ₹2.07 Billion Amid Export Resilience

STORIES YOU MAY LIKE

AI Leadership Revolution Unleashed: NSBT & Findability's Bootcamp Arms India's Execs for Tomorrow

Unlocking India’s Future: R&D Reinvented and $100 Billion FDI to Fuel Next-Gen Economy

Refex Industries Hit with ₹100.7 Cr Tax + Penalty Demand: Appeal Battle Looms